Tsuneyama K, Nose M, Nisihara M, Katayanagi K, Harada K, Nakanuma Y
Department of Pathology, School of Medicine, Kanazawa University, Kanazawa, Japan.
Pathol Int. 2001 Jun;51(6):418-24. doi: 10.1046/j.1440-1827.2001.01223.x.
MRL/MP mice bearing the lymphoproliferative gene lpr (known as MRL/MP-lpr/lpr or MRL/Ipr mice) are known to spontaneously develop severe autoimmune diseases such as glomerulonephritis, arteritis and arthritis at an early stage of their life. They have also been reported to develop severe sialadenitis, suggesting that this mouse could be a model for Sjögren's syndrome. Primary biliary cirrhosis, an autoimmune disease characterized by chronic non-suppurative destructive cholangitis and the occurrence of antimitochondrial antibodies, is frequently associated with Sjögren's syndrome. In this study, we examined whether cholangitis and/or antimitochondrial antibodies occur in this mouse model, using more than 100 young and old MRL/Ipr mice. We frequently found portal inflammation associated with cholangitis of small intrahepatic bile ducts, especially in older mice. There was also infiltration of inflammatory cells (monocytes) as well as CD4-positive T cells. Epithelioid granuloma and bile-duct loss were also occasionally found. These histological features resemble primary biliary cirrhosis. In addition, antimitochondrial antibodies were shown by immunocytochemistry to be present in the sera of MRL/Ipr mice. There is currently no established animal model for primary biliary cirrhosis. Therefore, further studies on MRL/Ipr mice, with respect to pathogenesis of primary biliary cirrhosis, are warranted.
携带淋巴增殖基因lpr的MRL/MP小鼠(称为MRL/MP-lpr/lpr或MRL/Ipr小鼠)在生命早期会自发发展出严重的自身免疫性疾病,如肾小球肾炎、动脉炎和关节炎。据报道,它们还会发展出严重的涎腺炎,这表明这种小鼠可能是干燥综合征的模型。原发性胆汁性肝硬化是一种以慢性非化脓性破坏性胆管炎和抗线粒体抗体出现为特征的自身免疫性疾病,常与干燥综合征相关。在本研究中,我们使用100多只年轻和年老的MRL/Ipr小鼠,检查了这种小鼠模型中是否发生胆管炎和/或抗线粒体抗体。我们经常发现与肝内小胆管胆管炎相关的门静脉炎症,尤其是在老年小鼠中。还存在炎症细胞(单核细胞)以及CD4阳性T细胞的浸润。偶尔也会发现上皮样肉芽肿和胆管丢失。这些组织学特征类似于原发性胆汁性肝硬化。此外,免疫细胞化学显示MRL/Ipr小鼠血清中存在抗线粒体抗体。目前尚无原发性胆汁性肝硬化的成熟动物模型。因此,有必要对MRL/Ipr小鼠进行关于原发性胆汁性肝硬化发病机制的进一步研究。